Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Gainers

  • Adagio Therapeutics (NASDAQ:ADGI) shares increased by 52.2% to $5.86 during Wednesday's pre-market session. The company's market cap stands at $651.9 million.
  • NanoVibronix (NASDAQ:NAOV) stock increased by 30.36% to $1.18. The market value of their outstanding shares is at $32.9 million.
  • Vyant Bio (NASDAQ:VYNT) stock rose 26.66% to $1.71. The market value of their outstanding shares is at $49.5 million. The company's, Q4 earnings came out today.
  • Sonoma Pharmaceuticals (NASDAQ:SNOA) stock rose 17.26% to $3.94. The company's market cap stands at $12.2 million.
  • China SXT Pharmaceuticals (NASDAQ:SXTC) stock rose 15.76% to $0.34. The market value of their outstanding shares is at $9.8 million.
  • Vir Biotechnology (NASDAQ:VIR) shares moved upwards by 12.88% to $25.49. The company's market cap stands at $3.3 billion.

Losers

  • Calithera Biosciences (NASDAQ:CALA) shares declined by 33.9% to $0.4 during Wednesday's pre-market session. The market value of their outstanding shares is at $29.5 million.
  • UpHealth (NYSE:UPH) stock fell 16.67% to $1.65. The market value of their outstanding shares is at $238.0 million. The company's, Q4 earnings came out today.
  • OpGen (NASDAQ:OPGN) stock declined by 8.24% to $0.78. The market value of their outstanding shares is at $36.2 million. As per the news, the Q4 earnings report came out yesterday.
  • Omeros (NASDAQ:OMER) stock declined by 7.88% to $5.85. The company's market cap stands at $366.9 million.
  • Geron (NASDAQ:GERN) shares decreased by 7.04% to $1.19. The market value of their outstanding shares is at $385.2 million.
  • Cocrystal Pharma (NASDAQ:COCP) shares fell 7.01% to $0.53. The market value of their outstanding shares is at $52.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.